Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease (Q33244259)

24 July 2017

Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

24 July 2017

0 references

0 references

Stefanie Joos

1

0 references

Joachim Szecsenyi

series ordinal

3

object named as

Joachim Szecsenyi

1 reference

24 July 2017

2

Thomas Rosemann

1 reference

24 July 2017

4

Eckhart G Hahn

1 reference

24 July 2017

Stefan N Willich

5

1 reference

PubMed ID

16716218

24 July 2017

Benno Brinkhaus

series ordinal

6

1 reference

24 July 2017

22 May 2006

1 reference

BMC Complementary and Alternative Medicine

24 July 2017

1 reference

24 July 2017

6

1 reference

24 July 2017

19

1 reference

https://scigraph.springernature.com/pub.10.1186/1472-6882-6-19

24 July 2017

0 references

cites work

Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

Acupuncture and Moxibustion in the Treatment of Active Crohn’s Disease: A Randomized Controlled Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

Therapy of active Crohn disease with Boswellia serrata extract H 15

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

What is complementary medicine?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

Effects of Boswellia serrata gum resin in patients with ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

Complementary medicine in Europe

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

Ethnic differences in complementary and alternative medicine use among cancer patients

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-6-19

Complementary medicine use in children and young adults with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-6-19

Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-6-19

Outcome and costs of homoeopathic and conventional treatment strategies: a comparative cohort study in patients with chronic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-6-19

[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease]

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-6-19

Complementary Alternative Medicine in Patients with Inflammatory Bowel Disease: Use and Attitudes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1539021

23 cases of chronic nonspecific ulcerative colitis treated by acupuncture and moxibustion

31 October 2018

1 reference

12 December 2020

[Use and acceptance of classical natural and alternative medicine in Germany--findings of a representative population-based survey]

1 reference

12 December 2020

[S3-guidelines--sedation in gastrointestinal endoscopy]

1 reference

12 December 2020

[Evaluation and utilization of complementary medical procedures--a survey of 793 physicians in general practice and the clinic]

1 reference

12 December 2020

Treatment of ulcerative colitis with acupuncture

1 reference

12 December 2020

Relationship between the use of unconventional therapies and disease-related concerns: A study of patients with inflammatory bowel disease

1 reference

12 December 2020

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6882-6-19

1 reference

PubMed ID

16716218

Dimensions Publication ID

24 July 2017

0 references

1 reference

24 July 2017

1 reference

PubMed ID

16716218